These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 31963435)

  • 1. Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson's Disease.
    Sironi L; Restelli LM; Tolnay M; Neutzner A; Frank S
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell biology of Parkinson's disease.
    Panicker N; Ge P; Dawson VL; Dawson TM
    J Cell Biol; 2021 Apr; 220(4):. PubMed ID: 33749710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Parkinson's disease-related genes act in mitochondrial homeostasis.
    Sai Y; Zou Z; Peng K; Dong Z
    Neurosci Biobehav Rev; 2012 Oct; 36(9):2034-43. PubMed ID: 22771336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia and astrocyte dysfunction in parkinson's disease.
    Kam TI; Hinkle JT; Dawson TM; Dawson VL
    Neurobiol Dis; 2020 Oct; 144():105028. PubMed ID: 32736085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural genomic variations and Parkinson's disease.
    Bandrés-Ciga S; Ruz C; Barrero FJ; Escamilla-Sevilla F; Pelegrina J; Vives F; Duran R
    Minerva Med; 2017 Oct; 108(5):438-447. PubMed ID: 28541025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction in genetic animal models of Parkinson's disease.
    Trancikova A; Tsika E; Moore DJ
    Antioxid Redox Signal; 2012 May; 16(9):896-919. PubMed ID: 21848447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease model organism for Parkinson disease: Drosophila melanogaster.
    Aryal B; Lee Y
    BMB Rep; 2019 Apr; 52(4):250-258. PubMed ID: 30545438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of Parkinson's disease.
    Yang YX; Wood NW; Latchman DS
    Neuroreport; 2009 Jan; 20(2):150-6. PubMed ID: 19151598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum.
    Creed RB; Menalled L; Casey B; Dave KD; Janssens HB; Veinbergs I; van der Hart M; Rassoulpour A; Goldberg MS
    Neuroscience; 2019 Jun; 409():169-179. PubMed ID: 31029729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's Disease-Related Genes and Lipid Alteration.
    Fais M; Dore A; Galioto M; Galleri G; Crosio C; Iaccarino C
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the biochemical pathways altered by mutated parkinson-related genes and chronic exposure to manganese.
    Roth JA
    Neurotoxicology; 2014 Sep; 44():314-25. PubMed ID: 25149416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
    Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
    Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From genes to proteins in mendelian Parkinson's disease: an overview.
    Pirkevi C; Lesage S; Brice A; Başak AN
    Anat Rec (Hoboken); 2009 Dec; 292(12):1893-901. PubMed ID: 19943343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease and mitophagy: an emerging role for LRRK2.
    Singh F; Ganley IG
    Biochem Soc Trans; 2021 Apr; 49(2):551-562. PubMed ID: 33769432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease.
    Thomas B; Beal MF
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endoplasmic reticulum/mitochondria interface: a subcellular platform for the orchestration of the functions of the PINK1-Parkin pathway?
    Erpapazoglou Z; Corti O
    Biochem Soc Trans; 2015 Apr; 43(2):297-301. PubMed ID: 25849933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
    Dodson MW; Guo M
    Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.